Document Detail

Late results of a prospective study of direct intra-arterial urokinase infusion for peripheral arterial and bypass graft occlusions.
MedLine Citation:
PMID:  7655844     Owner:  NLM     Status:  MEDLINE    
The outcome of 72 direct intra-arterial urokinase infusions was studied prospectively. Thirty four were performed for native arterial occlusion and 38 for bypass graft occlusion; the immediate success rates were 67.5 and 84% respectively. The overall incidence of complications was 26%. Median follow-up was 36 (range 1-60) months. Seventeen patients (27%) died during follow-up; nine (14%) required a major amputation. Among patients with native arterial occlusion, 29% had no adjunctive procedure after thrombolysis; of these patients, 85% remained patent at a median of 21 (range 3-42) months. Among bypass occluded patients, only two (6%) had no lesion revealed after successful lysis; both bypasses remain patent at 54 and 58 months respectively. For patients treated with balloon angioplasty immediately after successful thrombolysis, 62% with native arterial occlusion remained patent at a median of 39 (range 2-60) months, whereas only 27% of bypass occlusion patients were patent at a median of 11 (range 2-40) months. Of patients requiring a surgical procedure after thrombolysis, 23 new bypasses (15 vein, eight prosthetic) were placed (nine in native arterial occlusion patients, 14 in bypass occlusion patients). In addition, there were 15 other surgical procedures, including six thrombectomies, four vein patch angioplasties, four vein jump grafts and one endarterectomy. The primary and secondary patencies for the 15 new vein bypasses placed were 81 and 88% respectively at a median follow-up of 36 months. Good immediate results were experienced with urokinase thrombolysis for peripheral arterial and graft occlusions. However, multiple adjunctive procedures were required to maintain patency.(ABSTRACT TRUNCATED AT 250 WORDS)
R T Chalmers; J J Hoballah; T F Kresowik; A Y Synn; N Nakagawa; W J Sharp; J D Corson
Related Documents :
12489904 - Aortic valve replacement under deep hypothermic circulatory arrest.
21721444 - Correlation of arterial, central venous and capillary lactate levels in septic shock pa...
16126484 - Non-invasive imaging of sutureless vein graft anastomosis with 16-slice multi-detector ...
25174714 - Recent developments in drug-eluting coronary stents.
3725134 - Outcome in patients subjected to early aneurysm operation and intravenous nimodipine.
25366384 - Is there already a place for endovascular treatment of the common femoral artery?
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Cardiovascular surgery (London, England)     Volume:  3     ISSN:  0967-2109     ISO Abbreviation:  Cardiovasc Surg     Publication Date:  1995 Jun 
Date Detail:
Created Date:  1995-10-05     Completed Date:  1995-10-05     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  9308765     Medline TA:  Cardiovasc Surg     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  293-7     Citation Subset:  IM    
Department of Surgery, University of Iowa Hospitals and Clinics, Iowa City 52242-1086, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Combined Modality Therapy
Follow-Up Studies
Graft Occlusion, Vascular / drug therapy*,  mortality
Infusions, Intra-Arterial
Ischemia / drug therapy*,  mortality
Leg / blood supply*
Middle Aged
Prospective Studies
Prosthesis Failure
Survival Rate
Thrombolytic Therapy / methods*
Thrombosis / drug therapy*,  mortality
Urokinase-Type Plasminogen Activator / administration & dosage*,  adverse effects
Reg. No./Substance:
EC Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Endothelial cell injury in the human saphenous vein: a comparative study of two valvulotomes.
Next Document:  Effects of completion angiography on the outcome of carotid endarterectomy.